Laurie Myers
Directeur des opérations chez CINGULATE INC.
Fortune : 1 692 $ au 31/05/2024
Profil
Laurie A.
Myers is currently the Chief Operating Officer at Cingulate Therapeutics LLC, Chief Operating Officer & Executive Vice President at Cingulate Works, Inc., and Chief Operating Officer & Executive VP at Cingulate, Inc. Previously, she worked as the Head-Marketing at Fidia Pharma USA, Inc. Dr. Myers holds an MBA from St. Joseph's University, undergraduate and graduate degrees from the University of Scranton, and a doctorate from New Jersey Medical School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CINGULATE, INC.
0,04% | 14/06/2024 | 2 414 ( 0,04% ) | 1 692 $ | 31/05/2024 |
Postes actifs de Laurie Myers
| Sociétés | Poste | Début |
|---|---|---|
| CINGULATE INC. | Directeur des opérations | 01/04/2017 |
Cingulate Therapeutics LLC
 Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Directeur des opérations | 01/11/2017 |
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Directeur des opérations | 01/04/2017 |
Anciens postes connus de Laurie Myers
| Sociétés | Poste | Fin |
|---|---|---|
Fidia Pharma USA, Inc.
 Fidia Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Part of P.&R. The company is based in Parsippany, NJ. The website is intended for use by US residents only. S.p.A, Fidia Pharma USA, Inc. is a pharmaceutical company. The company's product portfolio includes hyaluronic acid-based viscosupplement products. Fidia is committed to compliantly assisting its customers to ensure a smooth transition from WAC-based to ASP-based reimbursement. Fidia Pharma USA is a wholly owned subsidiary of Fidia Farmaceutici S.p.A, which was founded in 1946. | Sales & Marketing | 01/11/2017 |
Formation de Laurie Myers
| St. Joseph's University | Masters Business Admin |
| University of Scranton | Graduate Degree |
| New Jersey Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CINGULATE INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Health Technology |
Fidia Pharma USA, Inc.
Fidia Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Part of P.&R. The company is based in Parsippany, NJ. The website is intended for use by US residents only. S.p.A, Fidia Pharma USA, Inc. is a pharmaceutical company. The company's product portfolio includes hyaluronic acid-based viscosupplement products. Fidia is committed to compliantly assisting its customers to ensure a smooth transition from WAC-based to ASP-based reimbursement. Fidia Pharma USA is a wholly owned subsidiary of Fidia Farmaceutici S.p.A, which was founded in 1946. | Health Technology |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Health Technology |
